EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 haemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries.

EKF specialises in developing tests for use in diabetes and anemia diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers, and has developed a portfolio of unique products that are helping clinicians with the fight against COVID-19.

PrimeStore® MTM is manufactured in the USA by EKF on behalf of Longhorn Vaccines and Diagnostics. PrimeStore MTM (Molecular Transport Medium) is an FDA-cleared sample collection device which deactivates viruses including COVID-19, influenza A, influenza B and mycobacterium tuberculosis allowing safe sample handling and transport, greatly reducing risk of infection to healthworkers, couriers, and lab technicians.

EKF is also a distributor of COVID-SeroKlir, an ELISA based test developed by Kantaro Inc. that detects the presence of IgG antibodies and provides a precise level that can be used to benchmark patient well-being. COVID-SeroKlir received FDA Emergency Use Authorisation (EUA) in November 2020 and is also CE marked.